The Latest Industry News & Insights from Qsight

With the end of year quickly approaching, the Aesthetics team at Guidepoint Qsight reviewed several years of trending data from Qsight Aesthetics Point-of-Sale and Qsight Aesthetics Tracker to unpack how behavior changes at MedSpas and Aesthetics practices in and around the holiday season.

The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.

Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.

As 2023 began with lingering economic concerns from 2022 (inflation, rising interest rates, risk of recession, etc.), the aesthetics industry’s hope for continued strong growth may be challenged.

With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.

Qsight’s HME/DME Purchasing Data provides clients with real-time intelligence into market share and purchasing insights in the non-acute medical device sector. We looked at our capture of insulin pumps from the top players to assess market share and market growth in the durable medical equipment channel.

Guidepoint Qsight’s healthcare facilities purchasing dataset captures trends in multiple segments within the MedTech space. We break down insights on these segments and the top manufacturers in the space.

As MedSpas become an important growth driver for the medical aesthetics industry in the U.S., Qsight’s aesthetics point-of-sale data...

With Abbott announcing the availability of its Amplatzer Steerable Delivery Sheath, Guidepoint Qsight took a closer look at the left atrial appendage closure market...

Qsight’s medical device purchasing dataset captures trends in several markets, including the orthopedics market. We took a closer look at top manufactures in the orthopedics segment to figure out which players were contributing to and detracting from overall growth of the market. Orthopedic procedures, largely elective, are more at risk to cancellations during the COVID-19…

With the Omicron COVID-19 variant sweeping across the nation, Guidepoint Qsight has gathered insights from physicians on staffing shortages and impact of Omicron at their facility. 46% physicians and administrators in our panel report that their facilities are currently understaffed and are currently hiring. Of the sites that were previously or are currently understaffed, almost…

  After the launch of Penumbra’s new product, the RED 72 catheter, we took a look at its impact and other historical trends in the ischemic stroke market. Qsight’s healthcare facility purchasing dataset shows the immediate impact of recalls and new product launches in the ischemic stroke market. After the recall of the Jet 7…